Z

Zeiss

Manufactures high-precision optical instruments and devices

Head of Strategic Marketing - Professional Education

Full-Time
No salary listed
Expert
Bachelor's, MBA
Bengaluru, Karnataka, India
In Person
Growth & MarketingMarketing Generalist & Management

About the job

Requirements
  • A bachelor's degree in Business, Marketing, Life Sciences, Engineering, Healthcare, or a related field.
  • 12–15 years of progressive experience in healthcare, medical technology, or life sciences marketing.
  • Demonstrated success in strategic marketing, product launches, key opinion leader engagement, and demand generation.
  • Proven experience leading and developing high-performing teams.
  • Strategic marketing and portfolio leadership.
  • Clinical advocacy and key opinion leader management.
  • Professional education program development.
  • Product launch excellence.
  • Digital marketing and demand generation.
  • Commercial acumen and business impact orientation.
  • Stakeholder management and influencing skills.
  • Leadership and talent development.
Responsibilities
  • Develop and execute the long-term marketing strategy for ZEISS Ophthalmology in India.
  • Define portfolio positioning, value propositions, and customer segmentation strategies across cataract, refractive, surgical, diagnostic, and digital workflows.
  • Identify growth opportunities across customer segments, channels, and care pathways.
  • Lead annual marketing planning, budgeting, and performance reviews.
  • Ensure all marketing investments are linked to measurable commercial outcomes.
  • Build and lead a structured national key opinion leader engagement and advocacy program.
  • Develop relationships with leading ophthalmologists, academic institutions, societies, and clinical influencers.
  • Identify and nurture emerging key opinion leaders to strengthen ZEISS’ future influence network.
  • Drive generation and dissemination of India-specific clinical evidence and success stories.
  • Measure advocacy impact through surgeon engagement, influence, and commercial outcomes.
  • Lead ZEISS Academy India as a strategic platform for surgeon development and clinical excellence.
  • Design and execute national education programs including wet labs, masterclasses, fellowships, simulation training, and digital learning initiatives.
  • Build scalable education models that strengthen surgeon capability, loyalty, and preference for ZEISS technologies.
  • Establish return-on-investment measurement frameworks for all education initiatives.
  • Lead congress and scientific engagement strategy across national and regional ophthalmology forums.
  • Lead end-to-end new product introduction and launch excellence.
  • Conduct market assessments, opportunity sizing, and launch planning.
  • Develop differentiated go-to-market strategies for new technologies and workflows.
  • Ensure launch readiness across Sales, Clinical, Service, Operations, and Global stakeholders.
  • Accelerate adoption and commercial success of newly launched products and services.
  • Develop integrated business-to-business, business-to-business-to-consumer, and patient-awareness programs that support business growth.
  • Create initiatives that enhance patient awareness and premium procedure adoption.
  • Partner with hospitals, eye-care chains, and key accounts to drive workflow utilization and patient conversion.
  • Develop customer journey programs that improve awareness, consideration, adoption, and advocacy.
  • Lead digital marketing strategy and marketing automation platforms.
  • Drive lead generation, nurturing, and conversion programs in partnership with Sales.
  • Utilize digital channels, webinars, social media, content marketing, and marketing automation to drive demand.
  • Establish performance dashboards and analytics frameworks to continuously improve return on investment.
  • Build a robust market intelligence capability covering customer needs, competitive activity, market trends, and emerging opportunities.
  • Translate insights into actionable business strategies and growth initiatives.
  • Support portfolio planning, product development, and commercial decision-making through data-driven recommendations.
  • Build, lead, and develop a high-performing marketing and professional education organization.
  • Create a culture of accountability, innovation, collaboration, and continuous learning.
  • Develop future marketing leaders through coaching, mentoring, and capability-building initiatives.
  • Foster strong partnerships across Sales, Clinical, Service, Finance, and Global teams.
  • Own the strategic marketing and professional education budget.
  • Ensure effective resource allocation and return on investment.
  • Maintain compliance with ZEISS policies, healthcare regulations, and ethical standards.
  • Provide regular business reviews and performance updates to leadership.
Desired Qualifications
  • An MBA.
  • Experience in ophthalmology, surgical devices, diagnostics, or premium healthcare markets.

About the company

ZEISS is a global leader in optics and optoelectronics, serving medical professionals, industrial manufacturers, consumers, and the semiconductor industry. It designs and sells high-precision optical instruments, medical devices, semiconductor manufacturing equipment, and vision care products such as corrective lenses and eye-health services. Its products rely on advanced optics and imaging technologies to deliver accurate inspection, diagnosis, and manufacturing outcomes across healthcare, industrial quality control, consumer optics, and chip fabrication. What sets ZEISS apart is its breadth and depth: a long-standing scale in multiple markets, integrated solutions across optics, imaging, metrology, and precision engineering, and a commitment to sustainability in electricity use and carbon emissions. The company’s goal is to advance optics and optoelectronics by providing reliable, high-quality tools and services worldwide while operating in a sustainable way.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$67.7M

Headquarters

Oberkochen, Germany

Founded

2001

Get referred to Zeiss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • First-half 2025/26 revenue reached €5.841 billion, with EBIT rising to €955 million.
  • ZEISS CLINIC 360 won FDA 510(k) clearance on August 19, 2026.
  • EURETINA 2026 launches expanded retina imaging, cataract systems, and DORC brand integration.

What critics are saying

  • ZEISS Meditec plans up to 1,000 cuts by 2029, signaling margin pressure.
  • Göttingen workers entered mediation in February 2026 after Zeiss targeted roughly 140 jobs.
  • ASML scanner timing controls ZEISS SMT revenue; any slip delays optics demand immediately.

What makes Zeiss unique

  • ZEISS supplies ASML's exclusive EUV optics, anchoring High-NA lithography through 2030.
  • ZEISS Medical Technology bundles imaging, software, and surgery across one ophthalmic workflow stack.
  • ZEISS CLINIC 360 and Collaborative Care tie devices, cloud analytics, and referrals together.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • Paid Vacation
  • Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

4%
Associated Press
Oct 12th, 2026
ZEISS launches NLX X-ray inspection and DUNE wafer warpage correction for advanced chip packaging

ZEISS Semiconductor Manufacturing Technology (SMT) has launched two systems for advanced chip packaging: ZEISS NLX and ZEISS DUNE. The company announced them in San Francisco on October 12, 2026, as chips grow more complex. ZEISS NLX inspects the inside of chip packages without damaging them. It helps manufacturers spot defects in connections between stacked dies early, and it handles 300-millimetre wafers in both process development and high-volume production. ZEISS DUNE measures the topography of a wafer and corrects wafer bow individually. This helps avoid yield losses in downstream processing and prepares bonding processes. ZEISS SMT is showing the systems at SEMICON West, alongside its photomask tools. The company is also marking 100 years of business in the US in 2026.

PR Newswire
Sep 24th, 2026
ZEISS unveils retinal imaging and surgical innovations at EURETINA 2026

ZEISS Medical Technology has announced expansions to its ZEISS Retina Workflow at the EURETINA 2026 congress in Vienna. The company introduced the ZEISS ALTA DUO 300, combining OCT and fundus imaging in a single device for streamlined retinal diagnostics. ZEISS also unveiled the HMDmd CR3, a head-mounted 3D display that connects with the ZEISS ARTEVO 850 surgical microscope. The company reported that its DORC ILM-BLUE and DORC MEMBRANEBLUE-DUAL vitreoretinal surgical dyes reached a 3 million milestone. Additionally, ZEISS announced that the DORC brand will be consolidated under the ZEISS brand name, unifying the company's ophthalmic offerings. The DORC TDC VELOCE cutter continues to show improvements in 27G vitrectomy procedures, with clinical data suggesting up to 41% shorter core vitrectomy times.

PR Newswire
Sep 17th, 2026
ZEISS expands retinal imaging portfolio with new ALTA DUO 300 multimodal OCT device

ZEISS Medical Technology has expanded its retinal imaging portfolio with the launch of ZEISS ALTA DUO 300, a fully automated, compact multimodal imaging solution. The device combines optical coherence tomography (OCT) and fundus photography in a single unit, designed to provide efficient retinal assessment for eye care practices. The ALTA DUO 300 features four key diagnostic technologies: automated structural OCT with reference database and reporting, true colour fundus camera, AI-enhanced OCT-Angiography, and full chamber depth anterior OCT scanning. The device aims to integrate retinal imaging into everyday patient care through simplified workflows. The product will be showcased at the European Society of Retina Specialists congress in Vienna from 1-4 October and will be available in select markets later in 2026.

Yahoo Finance
Aug 27th, 2026
ZEISS launches DORC EVA NEXUS cataract system at ESCRS in London

ZEISS Medical Technology has launched a cataract-only configuration of its DORC EVA NEXUS ophthalmic surgical system. The system features a cataract grade selection with up to four programmable presets, allowing surgeons to optimise phaco, aspiration, and irrigation settings for each surgical step. The solution includes VacuFlow VTi pump, SMART IOP, and EVA EQUIPHACO technologies, designed to provide streamlined performance, stability, and control during procedures. It integrates with the ZEISS Cataract Workflow portfolio. The system debuted at the European Society of Cataract and Refractive Surgeons congress in London. It will become available in select European countries from September 2026, with global rollout pending regulatory approvals. The technology expands ZEISS's existing EVA NEXUS platform, which previously focused on retina workflows.

PR Newswire
Aug 19th, 2026
ZEISS CLINIC 360 receives FDA clearance for cloud-based ophthalmic data management software

ZEISS Medical Technology announced FDA 510(k) clearance for ZEISS CLINIC 360, a cloud-based software solution that aggregates ophthalmic clinical data and provides advanced analytics. The browser-based platform combines diagnostic and medical data into a comprehensive patient view, helping clinicians evaluate disease progression and support treatment decisions. The solution integrates data from DICOM-enabled diagnostic devices, including ZEISS's CIRRUS, CLARUS and HFA systems, as well as third-party devices. It features disease-based summaries, interactive analysis tools, and collaboration capabilities through ZEISS Collaborative Care. ZEISS CLINIC 360 will be available in the US in early autumn 2026 on a subscription basis with low upfront costs. The platform complements ZEISS FORUM, the company's on-premise data management system, giving providers flexibility in choosing their preferred infrastructure approach.